Gastrointestinal tract cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) age =18 years; 2) diagnosed with GI tract cancer, including esophagus, stomach, and colorectum cancer; 3) first time to receive first cycle of Capecitabine or S-1 (i.e., OAA) treatment; 4) at least 4 cycles of OAA treatment are needed, and taking 21 days as one treatment cycle; 5) willing to participate.
Exclusion criteria
Exclusion criteria: 1) history of diagnosed mental problems (e.g., schizophrenia); 2) currently participating in new drug clinical trials; 3) medical certificate of being critically or terminally ill.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility (e.g.,eligibility rate, consent rate, attrition rate, intervention adherence, response rate of outcomes measurement);Acceptability (e.g., satisification and experience of receiving intervention);Adherence to oral anticancer agents ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Illness perception;Medication perception (e.g., medication belief, medication self-efficacy for appropriate medication use) ;Self-management behaviors on adherence to oral anticancer agents ; | — |
Countries
China
Contacts
The Chinese University of Hong Kong; The Affiliated Cancer Hospital of Shandong First Medical University